Treatment of attention-deficit/hyperactivity disorder

3-(5,6-Dichloro-pyridin-3-yl)-1S,5S-3,6-diazabicyclo[3.2.0]heptane and salts thereof are effective nicotinic receptor agonist compounds that demonstrated pharmacological effect for symptoms associated with attention-deficit/hyperactivity disorder.

Saved in:
Bibliographic Details
Main Authors Bain, Earle E, Abi-Saab, Walid M, Dutta, Sandeep, Garimella, Tushar S, Awni, Walid M, Saltarelli, Mario D
Format Patent
LanguageEnglish
Published 17.07.2012
Online AccessGet full text

Cover

More Information
Summary:3-(5,6-Dichloro-pyridin-3-yl)-1S,5S-3,6-diazabicyclo[3.2.0]heptane and salts thereof are effective nicotinic receptor agonist compounds that demonstrated pharmacological effect for symptoms associated with attention-deficit/hyperactivity disorder.